Integra Lifesciences Holdings (IART) Debt Ratio (2009 - 2026)
Integra Lifesciences Holdings recorded quarterly Debt Ratio of 0.5 in Q1 2026, up 1.86% quarter-over-quarter from 0.49 in Q4 2025, and up 73.61% year-over-year from 0.29 in Q1 2025.
Integra Lifesciences Holdings' Debt Ratio history runs 18 years deep, the most recent figure standing at 0.5 for Q1 2026.
- In Q1 2026, Debt Ratio rose 73.61% year-over-year to 0.5; the TTM figure through Mar 2026 stood at 0.5 (up 73.61% YoY), while the FY2025 annual figure was 0.49, up 19.32% from the prior year.
- Debt Ratio came in at 0.5 for Q1 2026 at Integra Lifesciences Holdings, up from 0.49 in the prior quarter.
- In the past five years, Debt Ratio ranged from a high of 0.5 in Q1 2026 to a low of 0.2 in Q4 2022.
- A 5-year average of 0.3 and a median of 0.29 in 2024 frame the typical range for Debt Ratio.
- Across the five-year window, Debt Ratio dropped 13.72% in 2022 and jumped 88.48% in 2024, its largest moves.
- Integra Lifesciences Holdings' Debt Ratio stood at 0.2 in 2022, then climbed by 10.09% to 0.22 in 2023, then surged by 88.48% to 0.41 in 2024, then grew by 19.32% to 0.49 in 2025, then increased by 1.86% to 0.5 in 2026.
- According to Business Quant data, Debt Ratio over the past three periods registered 0.5, 0.49, and 0.47 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Debt Ratio (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 0.31 |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 0.32 |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 0.31 |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 0.25 |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 0.04 |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 0.25 |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | - |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 0.27 |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 0.18 |
| 10 | Integra Lifesciences Holdings | 1.20 Bn | 939.16 Mn | 216.98 Mn | 0.50 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 0.50 |
| Dec 31, 2025 | 0.49 |
| Sep 30, 2025 | 0.47 |
| Jun 30, 2025 | 0.32 |
| Mar 31, 2025 | 0.29 |
| Dec 31, 2024 | 0.41 |
| Sep 30, 2024 | 0.29 |
| Jun 30, 2024 | 0.29 |
| Mar 31, 2024 | 0.29 |
| Dec 31, 2023 | 0.22 |
| Sep 30, 2023 | 0.23 |
| Jun 30, 2023 | 0.20 |
| Mar 31, 2023 | 0.21 |
| Dec 31, 2022 | 0.20 |
| Sep 30, 2022 | 0.23 |
| Jun 30, 2022 | 0.23 |
| Mar 31, 2022 | 0.24 |
| Dec 31, 2021 | 0.23 |
| Sep 30, 2021 | 0.23 |
| Jun 30, 2021 | 0.23 |
| Mar 31, 2021 | 0.26 |
| Dec 31, 2020 | 0.27 |
| Sep 30, 2020 | 0.28 |
| Jun 30, 2020 | 0.30 |
| Mar 31, 2020 | 0.30 |
| Dec 31, 2019 | 0.38 |
| Sep 30, 2019 | 0.39 |
| Jun 30, 2019 | 0.38 |
| Mar 31, 2019 | 0.39 |
| Dec 31, 2018 | 0.40 |
| Sep 30, 2018 | 0.45 |
| Jun 30, 2018 | 0.47 |
| Mar 31, 2018 | 0.56 |
| Dec 31, 2017 | 0.56 |
| Sep 30, 2017 | 0.48 |
| Jun 30, 2017 | 0.42 |
| Mar 31, 2017 | 0.43 |
| Dec 31, 2016 | 0.37 |
| Sep 30, 2016 | 0.25 |
| Jun 30, 2016 | 0.27 |
| Mar 31, 2016 | 0.28 |
| Dec 31, 2015 | 0.28 |
| Sep 30, 2015 | 0.28 |
| Jun 30, 2015 | 0.27 |
| Mar 31, 2015 | 0.26 |
| Dec 31, 2014 | 0.26 |
| Sep 30, 2014 | 0.27 |
| Jun 30, 2014 | 0.27 |
| Mar 31, 2014 | 0.27 |
| Dec 31, 2013 | 0.16 |
| Sep 30, 2013 | 0.29 |
| Jun 30, 2013 | 0.29 |
| Mar 31, 2013 | 0.28 |
| Dec 31, 2012 | 0.28 |
| Sep 30, 2012 | 0.27 |
| Jun 30, 2012 | 0.28 |
| Mar 31, 2012 | 0.14 |
| Dec 31, 2011 | 0.16 |
| Sep 30, 2011 | 0.16 |
| Jun 30, 2011 | 0.13 |
| Mar 31, 2011 | 0.20 |
| Dec 31, 2010 | 0.24 |
| Sep 30, 2010 | 0.22 |
| Jun 30, 2010 | 0.23 |
| Dec 31, 2009 | 0.25 |